Real-Time Monitoring of Photocytotoxicity in Nanoparticles-Based Photodynamic Therapy: A Model-Based Approach

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Benachour, Hamanou ^a,b   Bastogne, Thierry ^a,b,c   Toussaint, Magali ^a,b   Chemli, Yosra ^a,b   Sève, Aymeric ^d   Frochot, Céline ^d,e   Lux, François ^f,g   Tillement, Olivier ^f,g   Vanderesse, Régis ^a,h   Barberi Heyob, Muriel ^a,b,e,i  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^c UNIVERSITÉ HENRI POINCARÉ NANCY 1   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e CNRS   (France)

^f UNIVERSITÉ LYON 1   (France)

^g University of Lyon   (France)

^h LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

ⁱ CENTRE ALEXIS VAUTRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CARBOXYPHENYL) 10,15,20 TRIPHENYLCHLORIN; NANOPARTICLE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; REAL TIME IMPEDANCE BASED CELL ANALYSIS;

CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTER SYSTEMS; HUMANS; KINETICS; LIGHT; LINEAR MODELS; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TIME FACTORS;

EID: 84868704476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048617     Document Type: Article

References (51)

1. Praetorius NP, Mandal TK, (2007) Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul 1: 37-51.
2. Hong H, Zhang Y, Sun J, Cai W, (2009) Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4: 399-413.
3. Koo H, Huh MS, Sun IC, Yuk SH, Choi K, et al. (2011) In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 44: 1018-1028.
4. Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, et al. (2006) Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem 17: 728-734.
5. Caruso G, Caffo M, Alafaci C, Raudino G, Cafarella D, et al. (2011) Could nanoparticle systems have a role in the treatment of cerebral gliomas? Nanomedicine 7: 744-752.
6. Mohs AM, Provenzale JM, (2010) Applications of nanotechnology to imaging and therapy of brain tumors. Neuroimaging Clin N Am 20: 283-292.
7. Solomon M, D'Souza GG, (2011) Recent progress in the therapeutic applications of nanotechnology. Curr Opin Pediatr 23: 215-220.
8. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, et al. (2008) Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 26: 612-621.
9. Sun C, Lee JS, Zhang M, (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60: 1252-1265.
10. McCarthy JR, Weissleder R, (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60: 1241-1251.
11. Tassa C, Shaw SY, Weissleder R, (2011) Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44: 842-852.
12. Chouikrat R, Seve A, Vanderesse R, Benachour H, Barberi-Heyob M, et al. (2012) Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr Med Chem 19: 781-792.
13. Faure AC, Dufort S, Josserand V, Perriat P, Coll JL, et al. (2009) Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 5: 2565-2575.
14. Couleaud P, Bechet D, Vanderesse R, Barberi-Heyob M, Faure AC, et al. (2011) Functionalized silica-based nanoparticles for photodynamic therapy. Nanomedicine (Lond) 6: 995-1009.
15. Weishaupt KR, Gomer CJ, Dougherty TJ, (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36: 2326-2329.
16. Fingar VH, (1996) Vascular effects of photodynamic therapy. J Clin Laser Med Surg 14: 323-328.
17. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, et al. (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889-905.
18. Verma S, Watt GM, Mai Z, Hasan T, (2007) Strategies for enhanced photodynamic therapy effects. Photochem Photobiol 83: 996-1005.
19. Chatterjee DK, Fong LS, Zhang Y, (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60: 1627-1637.
20. Brevet D, Gary-Bobo M, Raehm L, Richeter S, Hocine O, et al. (2009) Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun (Camb) 1475-1477.
21. Vistejnova L, Dvorakova J, Hasova M, Muthny T, Velebny V, et al. (2009) The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. Neuro Endocrinol Lett 1: 121-127.
22. McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, et al. (2011) Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay. PLoS One 6: e20623.
23. Elisia I, Popovich DG, Hu C, Kitts DD, (2008) Evaluation of viability assays for anthocyanins in cultured cells. Phytochem Anal 19: 479-486.
24. Barbu E, Molnàr E, Tsibouklis J, Górecki DC, (2009) The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier. Expert Opin Drug Deliv 6: 553-565.
25. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC, et al. (2011) Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6: 446-465.
26. Soenen SJ, De Cuyper M, (2009) Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging 4: 207-219.
27. Gupta S, Dwarakanath BS, Muralidhar K, Koru-Sengul T, Jain V, (2010) Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminium phthalocyanine photodynamic treatment in a human glioma cell line. J Transl Med 8: 43.
28. Winther J, (1989) Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay. Br J Cancer 59: 869-872.
29. Li J, Guo D, Wang X, Wang H, Jiang H, et al. (2010) The Photodynamic Effect of Different Size ZnO Nanoparticles on Cancer Cell Proliferation In Vitro. Nanoscale Res Lett 5: 1063-1071.
30. Quereda JJ, Martínez-Alarcón L, Mendoça L, Majado MJ, Herrero-Medrano JM, et al. (2010) Validation of xCELLigence real-time cell analyzer to assess compatibility in xenotransplantation with pig-to-baboon model. Transplant Proc 42: 3239-3243.
31. Thomas N, Pernot M, Vanderesse R, Becuwe P, Kamarulzaman E, et al. (2010) Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties. Biochem Pharmacol 80: 226-235.
32. Bastogne T, Samson A, Vallois P, Wantz-Mézières S, Pinel S, et al. (2010) Phenomenological modeling of tumor diameter growth based on a mixed effects model. J Theor Biol 262: 544-552.
33. Pazos MdC, Nader HB, (2007) Effect of photodynamic therapy on the extracellular matrix and associated components. Braz J Med Biol Res 40: 1025-1035.
34. Runnels JM, Chen N, Ortel B, Kato D, Hasan T, (1999) BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells. Br J Cancer 80: 946-953.
35. Margaron P, Sorrenti R, Levy JG, (1997) Photodynamic therapy inhibits cell adhesion without altering integrin expression. Biochim Biophys Acta 1359: 200-210.
36. Yang TH, Chen CT, Wang CP, Lou PJ, (2007) Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. Oral Oncol 43: 358-365.
37. Volanti C, Gloire G, Vanderplasschen A, Jacobs N, Habraken Y, et al. (2004) Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23: 8649-8658.
38. Mariani V, Ponti J, Giudetti G, Broggi F, Marmorato P, et al. (2012) Online monitoring of cell metabolism to assess the toxicity of nanoparticles: The case of cobalt ferrite. Nanotoxicology 6: 272-287.
39. Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, et al. (2011) Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proc Natl Acad Sci USA 108: 20078-20083.
40. Chen SW, Yang JM, Yang JH, Yang SJ, Wang JS, (2012) A computational modeling and analysis in cell biological dynamics using electric cell-substrate impedance sensing (ECIS). Biosens Bioelectron 33: 196-203.
41. Kirstein SL, Atienza JM, Xi B, Zhu J, Yu N, et al. (2006) Live cell quality control and utility of real-time cell electronic sensing for assay development. Assay Drug Dev Technol 4: 545-553.
42. Heng BC, Das GK, Zhao X, Ma LL, Tan TT, et al. (2010) Comparative cytotoxicity evaluation of lanthanide nanomaterials on mouse and human cell lines with metabolic and DNA-quantification assays. Biointerphases 5: FA88-97.
43. Hanusová V, Králová V, Schröterová L, Trilecová L, Pakostová A, et al. (2010) The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells. Xenobiotica 40: 681-690.
44. Soenen SJ, Brisson AR, De Cuyper M, (2009) Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 30: 3691-3701.
45. Liu Y, Chen Z, Liu C, Yu D, Lu Z, et al. (2011) Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials 32: 5167-5176.
46. Bazzi R, Flores-Gonzalez MA, Louis C, Lebbou K, Dujardin C, et al. (2003) Synthesis and luminescent properties of sub-5-nm lanthanide oxides nanoparticles. Journal of Luminescence 102: 445-450.
47. Bazzi R, Flores MA, Louis C, Lebbou K, Zhang W, et al. (2004) Synthesis and properties of europium-based phosphors on the nanometer scale: Eu2O3, Gd2O3:Eu, and Y2O3:Eu. J Colloid Interface Sci 273: 191-197.
48. Louis C, Bazzi R, Marquette CA, Bridot JL, Roux S, et al. (2005) Nanosized hybrid particles with double luminescence for biological labelling. Chem Mater 17: 1673-1682.
49. Benachour H, Sève A, Bastogne T, Frochot C, Vanderesse R, et al. (2012) Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics. In press.
50. Lux F, Mignot A, Mowat P, Louis C, Dufort S, et al. (2011) Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl 50: 12299-12303.
51. Urcan E, Haertel U, Styllou M, Hickel R, Scherthan H, et al. (2010) Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent Mater 26: 51-58.